Critical Comparison: Rejuvel Bio-Sciences (OTCMKTS:NUUU) and Solesence (NASDAQ:SLSN)

Rejuvel Bio-Sciences (OTCMKTS:NUUU) and Solesence (NASDAQ:SLSN) are both consumer staples companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, dividends and risk.

Profitability

This table compares Rejuvel Bio-Sciences and Solesence’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Rejuvel Bio-Sciences	N/A	N/A	N/A
Solesence	1.72%	6.53%	1.94%

Earnings and Valuation

This table compares Rejuvel Bio-Sciences and Solesence”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rejuvel Bio-Sciences	N/A	N/A	N/A	N/A	N/A
Solesence	$52.35 million	1.74	$4.24 million	$0.01	129.00

Solesence has higher revenue and earnings than Rejuvel Bio-Sciences.

Analyst Recommendations

This is a summary of current ratings and price targets for Rejuvel Bio-Sciences and Solesence, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rejuvel Bio-Sciences	0	0	0	0	0.00
Solesence	1	0	0	0	1.00

Given Rejuvel Bio-Sciences’ higher probable upside, equities research analysts plainly believe Rejuvel Bio-Sciences is more favorable than Solesence.

Volatility and Risk

Rejuvel Bio-Sciences has a beta of 0.63, indicating that its share price is 37% less volatile than the S&P 500. Comparatively, Solesence has a beta of 1.1, indicating that its share price is 10% more volatile than the S&P 500.

Insider and Institutional Ownership

70.2% of Solesence shares are owned by institutional investors. 4.8% of Solesence shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Solesence beats Rejuvel Bio-Sciences on 8 of the 9 factors compared between the two stocks.

About Rejuvel Bio-Sciences

Rejuvel Bio-Sciences, Inc., a development stage company, produces, distributes, markets, and sells skin care products worldwide. The company primarily offers skin cream under the Rejuvel brand. It also intends to develop, build, and sell environmental management solutions that use electron particle accelerator technology for the treatment of drinking water, municipal and industrial wastewater, sludge, and produced water from oil and gas fracturing activities. The company was formerly known as Technology Applications International Corporation and changed its name to Rejuvel Bio-Sciences, Inc. in June 2015. Rejuvel Bio-Sciences, Inc. was founded in 2009 and is headquartered in Miami, Florida.

About Solesence

Nanophase Technologies Corporation provides engineered materials, formulation development, and commercial manufacturing with an integrated family of technologies in the United States. It offers surface engineered zinc oxide and titanium dioxide for sunscreens and personal care products; fully formulated cosmetics, sun care, and skin care under the Solésence brand name; and advanced materials products, such as architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics, and various surface finishing technologies applications. The company was incorporated in 1989 and is headquartered in Romeoville, Illinois.